Cargando…
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780398/ https://www.ncbi.nlm.nih.gov/pubmed/27042080 http://dx.doi.org/10.2147/TCRM.S103196 |
| _version_ | 1782419758620082176 |
|---|---|
| author | Chen, Meng Zhou, Quan |
| author_facet | Chen, Meng Zhou, Quan |
| author_sort | Chen, Meng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4780398 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47803982016-04-01 The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions Chen, Meng Zhou, Quan Ther Clin Risk Manag Letter Dove Medical Press 2016-03-02 /pmc/articles/PMC4780398/ /pubmed/27042080 http://dx.doi.org/10.2147/TCRM.S103196 Text en © 2016 Chen and Zhou. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Letter Chen, Meng Zhou, Quan The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title | The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title_full | The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title_fullStr | The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title_full_unstemmed | The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title_short | The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions |
| title_sort | use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising cyp2c19 pharmacogenetics and drug interactions |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780398/ https://www.ncbi.nlm.nih.gov/pubmed/27042080 http://dx.doi.org/10.2147/TCRM.S103196 |
| work_keys_str_mv | AT chenmeng theuseoforalsuspensionandrationallyprescribingalternativesmaybesupplementaltotheimplementationofclopidogrelnewalgorithmcomprisingcyp2c19pharmacogeneticsanddruginteractions AT zhouquan theuseoforalsuspensionandrationallyprescribingalternativesmaybesupplementaltotheimplementationofclopidogrelnewalgorithmcomprisingcyp2c19pharmacogeneticsanddruginteractions AT chenmeng useoforalsuspensionandrationallyprescribingalternativesmaybesupplementaltotheimplementationofclopidogrelnewalgorithmcomprisingcyp2c19pharmacogeneticsanddruginteractions AT zhouquan useoforalsuspensionandrationallyprescribingalternativesmaybesupplementaltotheimplementationofclopidogrelnewalgorithmcomprisingcyp2c19pharmacogeneticsanddruginteractions |